Preoperative Fasting Duration and Gastric Residue in Pediatric Upper Gastrointestinal Endoscopy

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age0-17
SponsorBursa Sevket Yilmaz Training and Research Hospital

About this trial

This retrospective observational study aims to evaluate the relationship between preoperative fasting duration and gastric residue in pediatric patients undergoing upper gastrointestinal endoscopy for gastrointestinal symptoms or pathology. The study will assess the associations between gastric residue, gastrointestinal symptoms, underlying gastrointestinal diseases, and endoscopic findings. Data will be retrospectively collected from hospital records, anesthesia records, and endoscopy reports to investigate whether prolonged fasting duration reliably predicts an empty stomach in pediatric gastrointestinal patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Pediatric patients aged under 18 years

Patients who underwent upper gastrointestinal endoscopy for gastrointestinal symptoms or pathology

Patients with available hospital records, anesthesia records, and endoscopy reports

Patients with documented preoperative fasting duration

Disqualifiers

Patients aged 18 years or older

Patients with missing or incomplete data for key study variables

Patients without documented preoperative fasting duration

Patients without documented gastric residue assessment during endoscopy

Trial population

Pediatric patients undergoing upper gastrointestinal endoscopy for evaluation of gastrointestinal symptoms or suspected gastrointestinal pathology at a single tertiary care center will be included in this retrospective observational study. The study population will consist of patients evaluated between January 2025 and April 2026. Data will be retrospectively obtained from hospital information systems, anesthesia records, electronic medical records, and endoscopy reports. The study will evaluate demographic characteristics, gastrointestinal symptoms, preoperative fasting duration, endoscopic findings, underlying gastrointestinal diseases, medication use, and endoscopically observed gastric residue.

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • Upper Gastrointestinal Endoscopy

    Procedure/Surgery

    Upper gastrointestinal endoscopy performed for evaluation of gastrointestinal symptoms or pathology in pediatric patients. The procedure was conducted under sedation or anesthesia according to institutional clinical practice. Endoscopic findings and endoscopically observed gastric residue were retrospectively evaluated from medical records and endoscopy reports.

Treatment groups

110 Participants
are divided into 1 treatment group
Group A: Pediatric Upper Gastrointestinal Endoscopy Cohort1 intervention

Trial outcomes

Primary outcomes

1

Gastric Residue Severity

Severity of endoscopically observed gastric residue during upper gastrointestinal endoscopy, categorized as none, mild, moderate, or severe according to endoscopic findings documented in medical records and endoscopy reports.

Time frame
At the time of upper gastrointestinal endoscopy

Secondary outcomes

1

Clinically Relevant Gastric Residue

Presence of clinically relevant gastric residue during upper gastrointestinal endoscopy, defined as moderate or severe gastric residue based on endoscopic observation documented in medical and endoscopy records.

Time frame
At the time of upper gastrointestinal endoscopy

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: